---
title: "SINOTHERAPEUTICS: Net profit of 45.5857 million yuan in the first half of 2025, a year-on-year decrease of 15.82%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254117010.md"
description: "SINOTHERAPEUTICS announced that in the first half of 2025, the operating income was 220 million yuan, a year-on-year increase of 0.74%. The net profit was 45.5857 million yuan, a year-on-year decrease of 15.82%. The company plans to distribute a cash dividend of 0.25 yuan for every 10 shares to all shareholders, with a total cash dividend distribution of 11.2251 million yuan, accounting for 24.62% of the net profit attributable to the parent company's shareholders for the period from January to June 2025"
datetime: "2025-08-22T07:59:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254117010.md)
  - [en](https://longbridge.com/en/news/254117010.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254117010.md)
---

# SINOTHERAPEUTICS: Net profit of 45.5857 million yuan in the first half of 2025, a year-on-year decrease of 15.82%

SINOTHERAPEUTICS announced that its operating revenue in the first half of 2025 was 220 million yuan, a year-on-year increase of 0.74%. The net profit was 45.5857 million yuan, a year-on-year decrease of 15.82%. The company plans to distribute a cash dividend of 0.25 yuan for every 10 shares to all shareholders, with a total cash dividend of 11.2251 million yuan, accounting for 24.62% of the net profit attributable to the parent company's shareholders for the period from January to June 2025

### Related Stocks

- [688247.CN](https://longbridge.com/en/quote/688247.CN.md)

## Related News & Research

- [IPO Winners & Losers Podcast: Cerebras, SpaceX, and the AI Takeover](https://longbridge.com/en/news/286957979.md)
- [Former Spanish Prime Minister Zapatero is under investigation linked to airline bailout](https://longbridge.com/en/news/287039440.md)
- [JD Vance Says Hunter Biden Is 'Welcome' To Seek Payout From DOJ's $1.8 Billion 'Slush Funds'—'The President...Has Pardoned..'](https://longbridge.com/en/news/287054505.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Assessing BlueNord (OB:BNOR) Valuation After Its US$400 Million Refinancing Deal](https://longbridge.com/en/news/287098111.md)